Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare ...

Early results of Eli Lilly’s next generation of weight loss drugs appear to show promise, possibly leading to even faster ...

The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month ...

Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk ...

The race to develop the next generation of weight loss drugs has taken an interesting new turn. In recent research, Eli Lilly ...

The drugmaker said it would launch late-stage trials of the drug after participants lost as much as 20% of their body weight.

David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...

(Reuters) -U.S. President Donald Trump on Thursday is expected to announce a deal with officials from Eli Lilly and Novo ...

David Ricks' remarks followed a recent White House event where Trump announced his administration had reached a deal to lower ...

Eli Lilly hiked its outlook as sales soared for its popular weight-loss drugs Zepbound and Mounjaro.  The company also recently announced a partnership with Walmart that will expand access to Zepbound ...